October 12, 2015
Allergan’s AVYCAZTM potent in vitro activity against certain common Enterobacteriaceae pathogens
Allergan’s researchers have presented data at IDWeek from the International Network for Optimal Resistance Monitoring (INFORM) program that monitors the prevalence of resistant bacteria and changing trends of resistance, as well as the in vitro activity of antibiotics against these pathogens.